Literature DB >> 2321962

Clastogenic inosine nucleotide as components of the chromosome breakage factor in scleroderma patients.

C Auclair1, A Gouyette, A Levy, I Emerit.   

Abstract

In the present study, we attempted to identify the chemical nature of the clastogenic factor (CF) from patients with progressive systemic sclerosis (scleroderma). Computerized mass spectrometry of clastogenic fractions obtained by HPLC of plasma ultrafiltrates detected molecular peaks compatible with inosine triphosphate and inosine diphosphate (ITP and IDP). The concomitant detection of IDP, together with ITP, and the absence of these peaks in nonclastogenic fractions and corresponding control fractions are arguments in favor of a biological relevance of these observations. The most important confirmation came from the clastogenic effect of commercial ITP and IDP added to the culture medium of the test cultures. The induction of chromatid type damage by these substances in lymphocytes exposed in the G0 phase of their cell cycle and the prevention of this damage by superoxide dismutase are analogous to the observations with CF.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2321962     DOI: 10.1016/0003-9861(90)90253-u

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  10 in total

1.  Formation of a clastogenic factor by asbestos-treated rat pleural mesothelial cells.

Authors:  I Emerit; M C Jaurand; L Saint-Etienne; A Levy
Journal:  Agents Actions       Date:  1991-11

Review 2.  Radiation-induced bystander signalling in cancer therapy.

Authors:  Kevin M Prise; Joe M O'Sullivan
Journal:  Nat Rev Cancer       Date:  2009-04-20       Impact factor: 60.716

Review 3.  Clastogenic plasma factors: a short overview.

Authors:  Carita Lindholm; Anna Acheva; Sisko Salomaa
Journal:  Radiat Environ Biophys       Date:  2009-12-18       Impact factor: 1.925

4.  Chromosome abnormalities in peripheral lymphocytes from patients with progressive systemic sclerosis.

Authors:  F Takeuchi; K Nakano; H Yamada; E Kosuge; M Hirai; H Maeda; Y Moroi
Journal:  Rheumatol Int       Date:  1993       Impact factor: 2.631

5.  Superoxide-mediated clastogenesis and anticlastogenic effects of exogenous superoxide dismutase.

Authors:  I Emerit; F Garban; J Vassy; A Levy; P Filipe; J Freitas
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

6.  Clastogenic factors as potential biomarkers of increased superoxide production.

Authors:  Ingrid Emerit
Journal:  Biomark Insights       Date:  2007-12-11

7.  Transferable clastogenic activity in plasma from persons exposed as salvage personnel of the Chernobyl reactor.

Authors:  I Emerit; A Levy; L Cernjavski; R Arutyunyan; N Oganesyan; A Pogosian; H Mejlumian; T Sarkisian; M Gulkandanian; M Quastel
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

8.  Multiparameter analysis of clastogenic factors, pro-oxidant cytokines, and inflammatory markers in HIV-1-infected patients with asymptomatic disease, opportunistic infections, and malignancies.

Authors:  J Fuchs; N Oelke; M Imhof; F Ochsendorf; H Schöfer; G Oromek; A Alaoui-Youssefi; I Emerit
Journal:  Mol Med       Date:  1998-05       Impact factor: 6.354

9.  A new mechanism for DNA alterations induced by alpha particles such as those emitted by radon and radon progeny.

Authors:  B E Lehnert; E H Goodwin
Journal:  Environ Health Perspect       Date:  1997-09       Impact factor: 9.031

10.  NUDT16 and ITPA play a dual protective role in maintaining chromosome stability and cell growth by eliminating dIDP/IDP and dITP/ITP from nucleotide pools in mammals.

Authors:  Nona Abolhassani; Teruaki Iyama; Daisuke Tsuchimoto; Kunihiko Sakumi; Mizuki Ohno; Mehrdad Behmanesh; Yusaku Nakabeppu
Journal:  Nucleic Acids Res       Date:  2010-01-15       Impact factor: 16.971

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.